Steven Marso

Title: Innovations by Steven Marso in Vascular Health

Introduction

Steven Marso is an accomplished inventor based in Shawnee, Kansas, known for his significant contributions to vascular health. He holds two patents that focus on methods for inhibiting new tissue growth in blood vessels, particularly in patients who have experienced blood vessel injuries. His work aims to improve patient outcomes in vascular treatments.

Latest Patents

Marso's latest patents include a method for inhibiting new tissue growth in blood vessels in patients subjected to blood vessel injury. This invention involves administering a pharmaceutically effective amount of an inhibitor of the receptor for advanced glycation endproducts (RAGE) to inhibit new tissue growth in the subject's blood vessels. Additionally, he has developed a method for inhibiting neointimal formation in blood vessels, which also utilizes the same inhibitor to prevent complications following blood vessel injuries. Furthermore, his inventions include a method for preventing exaggerated restenosis in diabetic subjects, again focusing on the administration of RAGE inhibitors.

Career Highlights

Throughout his career, Steven Marso has worked with prestigious institutions such as Columbia University and The Cleveland Clinic Foundation. His research and innovations have made a significant impact on the field of vascular health, particularly in developing therapeutic methods that address critical issues related to blood vessel injuries.

Collaborations

Some of Marso's notable coworkers include David M. Stern and Ann Marie Schmidt, who have collaborated with him on various research projects and innovations in the medical field.

Conclusion

Steven Marso's contributions to vascular health through his innovative patents demonstrate his commitment to improving patient care and outcomes. His work continues to influence the medical community and offers promising solutions for patients with vascular injuries.